Ostara Biomedical submits final report to NC3Rs CRACK IT Solutions

Ostara Biomedical has submitted a final report to the NC3Rs CRACK IT Solutions fund. This fund awarded £24,319 to Ostara in partnership with Dr Ian Rosewell, Head of Transgenic Services at CRUK, for a solution entitled “A novel Product for reducing animal numbers in the production of transgenic mice”. Ostara Biomedical would like to thank the NC3Rs for their support, which has enabled this exciting 3Rs product to become closer to market.